HOUSTON--(BUSINESS WIRE)--Nov 30, 2020-- Kiromic BioPharma (“the Company”) (NASDAQ: KRBP), a pre-clinical stage biotechnology company using its proprietary DIAMOND ®...
HOUSTON--(BUSINESS WIRE)--Nov 30, 2020-- Kiromic BioPharma (“the Company”) (NASDAQ: KRBP), a pre-clinical stage biotechnology company using its proprietary DIAMOND ®...
WhatsApp us